Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Xilio Therapeutics, Inc. (XLO)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 26,671,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Xilio Therapeutics is a biotechnology company focused on harnessing the immune system to achieve clinical responses to improve the lives of patients with cancer. Co. is developing a number of tumor-selective, agents through various stages of development. Co.'s product candidates are XTX101, an anti-cytotoxic T-lymphocyte-associated protein 4 monoclonal antibody and XTX202, an interleukin 2 therapy. Co. is also developing its tumor-selective IL-12 product candidate, XTX301 and is focusing on preclinical studies for its tumor-selective IL-15 product candidate, XTX401. Co. has worldwide development and commercialization rights to all of its product candidates.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 485,250 485,250 485,250 485,250
Total Buy Value $368,790 $368,790 $368,790 $368,790
Total People Bought 1 1 1 1
Total Buy Transactions 1 1 1 1
Total Shares Sold 0 5,235 5,235 5,235
Total Sell Value $0 $4,240 $4,240 $4,240
Total People Sold 0 1 1 1
Total Sell Transactions 0 6 6 6
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 41
  Page 2 of 2  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Bay City Capital Fund Llc 10% Owner   –       –       •   2021-10-26 4 B $16.00 $5,000,000 I/I 312,500 1,129,490 1.5     -
   Bay City Capital Fund Llc 10% Owner   –       –       •   2021-10-26 4 A $0.00 $0 I/I 816,990 816,990     -
   Atlas Venture Opportunity Fund I, L.p. 10% Owner   –       –       •   2021-10-26 4 B $16.00 $3,000,000 I/I 187,500 735,942 1.5     -
   Atlas Venture Opportunity Fund I, L.p. 10% Owner   –       –       •   2021-10-26 4 A $0.00 $0 I/I 2,545,529 548,442     -
   Four Pines Master Fund Lp 10% Owner   –       –       •   2021-10-26 4 B $16.00 $8,000,000 I/I 500,000 1,256,472 1.5     -
   Four Pines Master Fund Lp 10% Owner   –       –       •   2021-10-26 4 A $0.00 $0 I/I 907,766 151,294     -
   Alexandria Venture Investments, Llc 10% Owner   –       –       •   2021-10-26 4 A $0.00 $0 D/D 166,423 166,423     -
   Williams John Charles 10% Owner   –       –       •   2021-10-21 3 IO $0.00 $0 D/D 0 100,080     -
   Clackson Timothy P 10% Owner   –       –       •   2021-10-21 3 IO $0.00 $0 I/I 0 70,888     -
   Clackson Timothy P 10% Owner   –       –       •   2021-10-21 3 IO $0.00 $0 D/D 0 20,068     -
   Fmr Corp 10% Owner   –       –       •   2021-10-21 3 IO $0.00 $0 I/I 0 26,315     -
   Russo Rene CEO and PresidentOfficer   •       •       •   2021-10-21 3 IO $0.00 $0 D/D 0 200,633     -
   Tomlinson Simon M 10% Owner   –       –       •   2021-10-21 3 IO $0.00 $0 D/D 0 131,117     -
   Atlas Venture Associates Opportunity I, Llc 10% Owner   –       –       •   2021-10-21 3 IO $0.00 $0 I/I 0 26,315     -
   Humphrey Rachel Director   –       •      –    2021-10-21 3 IO $0.00 $0 D/D 0 9,444     -
   Estate Of Ulrich Rodeck 10% Owner   –       –       •   2021-10-21 3 IO $0.00 $0 D/D 0 100,080     -

  41 Records found
  1  2    
  Page 2 of 2
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed